A novel liposomal formulation of dithranol for psoriasis: Preliminary results

Journal of Dermatology

Volumn 29, Issue 8, 2002, Pages 529-532

  Agarwal, Ravindra ^b   Saraswat, Abir ^a   Kaur, Inderjeet ^a   Katare, Om Prakash ^b   Kumar, Bhushan ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

^b PANJAB UNIVERSITY   (India)

Author keywords

Anthralin; Irritation; Liposome; Psoriasis; Topical therapy

Indexed keywords

DITHRANOL; LIPOSOME; ANTIINFLAMMATORY AGENT; DRUG CARRIER;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; FEMALE; GEL; HUMAN; MALE; PRURITUS; PSORIASIS; SKIN DISCOLORATION; PROSPECTIVE STUDY; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ANTHRALIN; ANTI-INFLAMMATORY AGENTS; DRUG CARRIERS; FEMALE; HUMANS; LIPOSOMES; MALE; PROSPECTIVE STUDIES; PSORIASIS;

EID: 0036667274     PISSN: 03852407     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1346-8138.2002.tb00321.x     Document Type: Article

References (11)

1. Pathophysiology and treatment of psoriasis
2. Irritation, staining and antipsoriatic activity of 10-acyl analogue of anthralin
3. How stable is dithranol? An investigation into the degradation of different dithranol formulations
4. Anthralin stability in various vehicles
5. Therapeutic progress with topical liposome drugs for skin disease
6. Interaction of external lipid vesicles with the skin
7. Diffusion of univalent ions across the lamellae of swollen phospholipids
8. Liposome preparations: A step forward in topical drug therapy for skin disease?
9. Attenuation of dermal toxicity of doxorubicin by liposome encapsulation
10. Preparation and in vitro evaluation of liposomal/niosomal delivery systems of antipsoriatic drug dithranol
11. Fabric staining properies and washability of a novel dithranol preparation